1. All Products
  2. IBUPROFEN, 100mg/5ml, oral susp., 150ml, bot.
Public Pricelist

IBUPROFEN, 100mg/5ml, oral susp., 150ml, bot.

https://medicalguidelines.msf.org/en/node/419
https://unicat.msf.org/cat/product/12086
STD DORAIBUP2S-

Valid Article

Former Code(s): -X
Article is intended to be used with children (<12 years) ONLY.
2.1 - Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
7.1 - For treatment of acute attack
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
M01AE01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

IBUPROFEN

Therapeutic Action

Non-steroidal anti-inflammatory (NSAID)

Analgesic, antipyretic

Indications

Mild to moderate pain, fever, rheumatic diseases

Instructions for use

In case of severe pain, it is recommended to combine it with paracetamol and/or an opioid analgesic.

The oral suspension is intended for paediatric use. Do not use in children under 3 months of age.

Storage

  • Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
  • After opening, the oral suspension must be stored between 8°C and 15°C.